Expression levels of FOXD1, a marker for stromagenesis, were ascertained by QPCR and shown to be highest in the blastemal-predominant tumours whose histology includes few or no UB-like structures (S4B Fig). This evidence concerns the gene FOXD1 and neoplasm.